Dilaudid-Hp Solution For Injection 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Dilaudid-HP: Solution for injection (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


In-Depth Information
Select a Medication

Dilaudid-HP 500mg/50ml Solution for Injection

NDC: 000742453
  • Prescription Required
  • Federally Controlled Drug
    (CSA Schedule)
  • FDA Approved





Sometimes used for but not FDA approved for the following conditions:
Severe Pain, Moderate Pain

Storage Information
Protect from light
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Dilaudid-HP 500mg/50ml Solution for Injection

Reported Side Effects for Dilaudid-HP 500mg/50ml Solution for Injection

Hallucinations Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Elated Mood Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Skin Redness Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Belching Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Dysphoria Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Dyskinesia Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Dysarthria Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Double Vision Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Confusion Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Chills Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Breathing Difficulties Incidence:
<2.0%*
Severity: SEVERE
Onset: RAPID
Blurred Vision Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Mass Trapped In Stomach Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Causing To Be Hungry Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Thoughts Of Suicide Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Decreased Memory Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Visual Impairment Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Rapid Heart Rate Incidence:
<2.0%*
Severity: MODERATE
Onset: RAPID
Restlessness Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Paranoia Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Rapid Muscle Twitches Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Miosis Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Decreased Sexual Desire Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Increased Urination Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Impotence (erectile Dysfunction) Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Thinking Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Hypoesthesia Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Overactive Reflexes Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Hyperesthesia Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
High Amylase Levels Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Hyperalgesia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Fast Eye Movements Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Pain Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Low Potassium Levels Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
High Uric Acid Level Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Hemorrhoids Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Painful Urination Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Dehydration Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Slow Heart Beat Incidence:
<2.0%*
Severity: SEVERE
Onset: RAPID
Distressed Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Inflamed Pancreas Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low Body Temperature Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Hole In Intestines Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Intestinal Blockage Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Brain Dysfunction Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Difficulty Swallowing Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Dry Eyes Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Balance Problems Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Ringing In Ears Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Shaking Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Retaining Urine Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Drowsiness Incidence:
1.0-15.0%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
1.0-6.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
1.0-8.0%*
Severity: MILD
Onset: RAPID
Tired Incidence:
1.0-11.0%*
Severity: MILD
Onset: EARLY
Weight Loss Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
Excessive Sweating Incidence:
1.0-6.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
1.0-11.0%*
Severity: MILD
Onset: DELAYED
Dry Mouth Incidence:
1.0-5.0%*
Severity: MILD
Onset: EARLY
Fluid Retention Incidence:
2.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
2.0-4.0%*
Severity: MILD
Onset: DELAYED
Withdrawal Incidence:
2.0-10.0%*
Severity: MODERATE
Onset: EARLY
Joint Pain Incidence:
2.0-6.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
2.0-11.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Skin Rash Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
3.0-8.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
3.0-7.0%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
3.0-4.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Throat Inflammation Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Heartburn Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
5.0-12.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
6.0-14.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
7.0-31.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
9.0-28.0%*
Severity: MILD
Onset: EARLY
Addiction Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Addiction Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Dilaudid-HP 500mg/50ml Solution for Injection

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Dilaudid-HP 500mg/50ml Solution for Injection(Hydromorphone Hydrochloride)
Alcohol and CNS Depressants(Hydromorphone Hydrochloride)
Avoid alcohol-containing drinks while taking this medicine. Using this drug along with alcohol can lead to serious side effects. You may feel drowsy or more tired when taking these drugs together. Do not drive or operate machinery until you know how this drug affects you, and especially if you are drinking alcohol-containing beverages. If you notice slurred speech, confusion, severe weakness, or difficulty breathing, contact your health care provider immediately.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More